Nu-Med Plus (NUMD) Share-based Compensation Growth (1y) (2013 - 2021)
Nu-Med Plus (NUMD) Share-based Compensation Growth (1y) (2013 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 7.56% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 21.13% |
| Mar 31, 2021 | 1,348.63% |
| Dec 31, 2020 | -3,512.26% |
| Sep 30, 2020 | 75.00% |
| Jun 30, 2020 | 1,122.30% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 106.30% |
| Sep 30, 2019 | -92.18% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | -1,138.53% |
| Sep 30, 2018 | 2,461.22% |
| Dec 31, 2017 | -111.35% |
| Sep 30, 2017 | 111.35% |
| Dec 31, 2016 | 141.32% |
| Sep 30, 2016 | -141.32% |
| Dec 31, 2015 | -208.44% |
| Sep 30, 2015 | 166.97% |
| Mar 31, 2015 | -88.71% |
| Sep 30, 2014 | 342.91% |